Clinical Trial Update: DF4 Master Study (Safety and Efficacy Study)

View source ↗

Summary

The DF4 Master Study, Biotronik's safety-and-efficacy trial, has completed and released results. The study evaluated outcomes in patients with ventricular tachy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Sudden Cardiac Death
• Ventricular Fibrillation
• Ventricular Tachycardia

Drugs mentioned

• DF4 Master System

Snippet

Sponsor: Biotronik SE & Co. KG | Conditions: Ventricular Tachycardia, Ventricular Fibrillation | Status: COMPLETED